Xilal Y. Rima
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
44
Citations
330
Est. group size
~27
Recurring co-author estimate
Active years
9
Publishing since 2018
This researcher studies extracellular vesicles (tiny particles cells release that carry molecules like lipids and microRNA) and their roles in diseases including breast cancer, Alzheimer's disease, and metabolic disorders. Their work combines cancer biology, particularly targeting the protein EZH2 to treat triple-negative breast cancer, with methods for detecting and analyzing circulating tumor cells and other disease biomarkers from blood and tissue samples. Recent projects also touch on immune cell behavior (neutrophils), gene therapy vector analysis (AAV), and metabolic disease models in mice.
Publication output has grown substantially over the past decade, rising from occasional single papers before 2021 to a steady 8-12 publications per year from 2023 onward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Single Particle Adsorption and Response Quantification for Functional AAVx Titer and Dose Analysis
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Decoding adipose–brain crosstalk: Distinct lipid cargo in human adipose‐derived extracellular vesicles modulates amyloid aggregation in Alzheimer's disease
Alzheimer s & Dementia · 2025
- Extracellular Particles to Track Cancer Biomarkers from Tissue to Biofluids
Journal of Dental Research · 2025
- Abstract P1-09-20: Enhancer of zeste homologue 2 (EZH2) inhibition in Triple Negative Breast Cancer (TNBC) attenuates tumor growth in vitro and in vivo altering the tumor immune microenvironment
Clinical Cancer Research · 2025
- Abstract 533: Attenuating EZH2-mediated metastasis and tumor growth by pharmacological-based approaches using three-dimensional in vitro culture models
Cancer Research · 2024
- 2033-LB: Dulaglutide Improves Metabolic Dysfunction–Associated Steatohepatitis (MASH), but Not Atherosclerosis, Independent of Weight Loss in Middle-Age LDLR-/- Mice
Diabetes · 2024
- Arp2/3 complex and the pentose phosphate pathway regulate late phases of neutrophil swarming
iScience · 2023
- Capture and Selective Release of Viable Circulating Tumor Cells
Methods in molecular biology · 2023
- Abstract P4-01-24: Targeting receptor tyrosine kinases in overcoming tamoxifen resistance and dormancy in invasive lobular cancer
Cancer Research · 2023
- Abstract P2-16-05: Targeting EZH2 to overcome chemoresistance in Triple Negative Breast Cancers Employing Combinatorial Approach
Cancer Research · 2023
- Abstract 332: Simultaneous inhibition of EZH2 and activation of dopamine D1 in an isotropic triple-negative breast cancer microgel model
Cancer Research · 2023
- Post-synthetic functionalization of a polysulfone scaffold with hydrazone-linked functionality
Polymer Chemistry · 2018
- bioRxiv (Cold Spring Harbor Laboratory)×7
- Cancer Research×6
- Diabetes×5
- Advanced Healthcare Materials×4
- Advanced Science×3
- Colin L. Hisey
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Daniel Dodd
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Eduardo Reátegui
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Federica Calore
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kalpana Deepa Priya Dorayappan
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile